Vorinostat Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 100 mg

Reference Brands: Zolinza (USA/EU), Vornat (India)

Category: Oncology Cancer Care

Product Description:

Vorinostat is an anticancer medication used in the treatment of cutaneous T-cell lymphoma (CTCL), a rare type of non-Hodgkin lymphoma that primarily affects the skin. It is generally prescribed for patients whose disease persists, worsens, or returns during or after treatment with other therapies. Vorinostat has demonstrated effectiveness in controlling disease progression and improving symptoms in patients with advanced or treatment-resistant CTCL.

Vorinostat belongs to a class of medicines known as histone deacetylase (HDAC) inhibitors. These drugs work by altering gene expression within cancer cells, which can slow the growth of malignant cells, stop their proliferation, and promote programmed cell death (apoptosis). Through this targeted mechanism, Vorinostat helps disrupt the survival and expansion of cancerous T-cells.

The drug is considered a significant advancement in the management of CTCL due to its efficacy and generally well-tolerated safety profile. In addition to its approved use, Vorinostat is also being studied for potential benefits in the treatment of other types of cancers. Ongoing research is evaluating its role both as a single therapy and in combination with other anticancer treatments to improve outcomes in various malignancies.